Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Nutr Diabetes. 2017 Dec 19;7(12):1. doi: 10.1038/s41387-017-0007-8.
Dietary fish is a rich source of Omega-3 poly-unsaturated fatty acids (PUFAs). These compounds may have protective effect against cardiovascular events possibly by modifying lipid profiles. Consequently, fish oil supplements are produced commercially to complement low fish intake. It is not clear if both interventions have similar effects. The aim of this trial was to compare the anti-hyperlipidemic effect of omega3 fatty acid supplements with fresh fish.
A total of 106 patients with hyperlipidemia were randomized. One group received 2 g/day of omega-3 capsules for a period of 8 weeks and the other group received a mean of 250 g trout fish twice weekly (for dinner and lunch) for the same time period. The effects of these diets on the lipid profile after the intervention were compared between the two groups.
Data from 48 patients in fish oil group and 47 patients from fish group was used for final analysis. In both groups, total cholesterol, non-HDL cholesterol, triglyceride (TG) levels, and Castelli I index (total cholesterol/HDL ratio) were reduced significantly following the treatment; however, dietary-fish intake had a more pronounced effect (-85.08 ± 74.82 vs. -30.75 ± 89.00, P < 0.001; 75.06 ± 35.43 vs. -16.93 ± 40.21, P < 0.001; -66.55 ± 30.79 vs. -12.7 ± 35.48, P = 0.003; and -0.77 ± 1.39 vs. -3.02 ± 1.85, P < 0.001; respectively). HDL level was increased in both groups with a higher effect in dietary fish group (4.47 ± 7.83 vs. 8.51 ± 8.79, P = 0.022). Atherogenic (Log [TG/HDL ratio]) and Castelli II (LDL/HDL ratio) indices did not change in fish oil group while were reduced significantly by fresh fish consumption (-0.04 ± 0.27 vs. -0.26 ± 0.17, P < 0.001; and 0.15 ± 0.7 vs. -1.32 ± 1.15, P < 0.001, respectively). LDL level was increased in the supplementation group, while it was significantly reduced in the dietary-fish group (+18.7 ± 24.97 vs. -22.75 ± 27.28, P < 0.001).
Consumption of fresh fish seems to be superior in positively modifying the lipid profiles which may have important translations in the occurrence of cardiovascular events.
食用鱼类是欧米伽-3 多不饱和脂肪酸(PUFAs)的丰富来源。这些化合物可能通过改变脂质谱对心血管事件具有保护作用。因此,商业上生产鱼油补充剂以补充低鱼类摄入量。目前尚不清楚这两种干预措施是否具有相似的效果。本试验旨在比较ω3 脂肪酸补充剂与新鲜鱼类的抗高脂血症作用。
共随机选择 106 例高脂血症患者。一组患者每天服用 2g 欧米伽-3 胶囊,持续 8 周,另一组患者每周两次(晚餐和午餐)平均摄入 250g 鳟鱼,持续相同时间。比较两组干预后血脂谱的变化。
鱼油组 48 例和鱼类组 47 例患者的数据用于最终分析。两组患者的总胆固醇、非高密度脂蛋白胆固醇、甘油三酯(TG)水平和 Castelli I 指数(总胆固醇/高密度脂蛋白比值)均明显降低;然而,食用鱼类对血脂谱的影响更为显著(-85.08±74.82 vs. -30.75±89.00,P<0.001;75.06±35.43 vs. -16.93±40.21,P<0.001;-66.55±30.79 vs. -12.7±35.48,P=0.003;-0.77±1.39 vs. -3.02±1.85,P<0.001)。两组患者的高密度脂蛋白水平均升高,而食用鱼类组的升高更为明显(4.47±7.83 vs. 8.51±8.79,P=0.022)。鱼油组的致动脉粥样硬化(Log [TG/HDL 比值])和 Castelli II(LDL/HDL 比值)指数没有变化,而新鲜鱼类摄入显著降低(-0.04±0.27 vs. -0.26±0.17,P<0.001;0.15±0.7 vs. -1.32±1.15,P<0.001)。补充组的 LDL 水平升高,而食用鱼类组的 LDL 水平显著降低(+18.7±24.97 vs. -22.75±27.28,P<0.001)。
食用新鲜鱼类似乎更能积极地改善血脂谱,这可能对心血管事件的发生有重要影响。